A much-anticipated test developed by Eli Lilly that detects the presence of proteins in the brain that are related to Alzheimer's disease was approved Friday by the FDA . Shirley Wang has details on Lunch Break.
Monday, April 9, 2012
Alzheimer Diagnosis Possible With Scan
A much-anticipated test developed by Eli Lilly & Co. that detects the presence of proteins in the brain that are related to Alzheimer's disease was approved Friday by the Food and Drug Administration.
The tool could enable clinicians to detect Alzheimer's earlier and more accurately in patients at the earliest sign of memory problems—a potential boon to treatment and developing drugs against the disease. Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment